Lbp Am Sa Sells 70,811 Shares of The Clorox Company $CLX

Key Points

• Lbp Am Sa significantly reduced its position in The Clorox Company by selling 70,811 shares, representing an 87.5% drop, leaving it with only 10,113 shares valued at $1.2 million.
• Clorox reported a strong quarterly earnings, with $2.87 EPS beating the consensus estimate by $0.63 and a revenue of $1.99 billion, showing a year-over-year increase of 4.5%.
• The company announced a quarterly dividend of $1.24, which equates to an annualized yield of 4.1%, set to be paid on November 6th to shareholders on record by October 22nd.

Lbp Am Sa reduced its position in The Clorox Company (NYSE:CLX - Free Report) by 87.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,113 shares of the company's stock after selling 70,811 shares during the quarter. Lbp Am Sa's holdings in Clorox were worth $1,214,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Hsbc Holdings PLC raised its stake in Clorox by 118.8% during the first quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company's stock worth $159,699,000 after acquiring an additional 589,544 shares in the last quarter. KBC Group NV raised its stake in Clorox by 688.7% during the first quarter. KBC Group NV now owns 587,679 shares of the company's stock worth $86,535,000 after acquiring an additional 513,171 shares in the last quarter. AQR Capital Management LLC raised its stake in Clorox by 412.1% during the first quarter. AQR Capital Management LLC now owns 598,758 shares of the company's stock worth $88,167,000 after acquiring an additional 481,846 shares in the last quarter. Goldman Sachs Group Inc. raised its stake in Clorox by 147.6% during the first quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company's stock worth $104,107,000 after acquiring an additional 421,453 shares in the last quarter. Finally, Nuveen LLC acquired a new position in Clorox during the first quarter worth $42,300,000. 78.53% of the stock is owned by institutional investors.

Clorox Stock Down 0.3%

Shares of NYSE CLX opened at $122.25 on Friday. The firm's 50-day simple moving average is $122.96 and its 200 day simple moving average is $129.78. The company has a market cap of $14.95 billion, a price-to-earnings ratio of 18.75, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52. The company has a quick ratio of 0.57, a current ratio of 0.84 and a debt-to-equity ratio of 5.15. The Clorox Company has a 12-month low of $116.53 and a 12-month high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.63. The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The firm's quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, research analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox's dividend payout ratio (DPR) is presently 76.07%.

Wall Street Analyst Weigh In

Several research firms have issued reports on CLX. Zacks Research upgraded Clorox from a "strong sell" rating to a "hold" rating in a research note on Monday. JPMorgan Chase & Co. increased their price objective on Clorox from $133.00 to $135.00 and gave the stock a "neutral" rating in a research note on Monday, September 8th. Morgan Stanley dropped their price objective on Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a research note on Friday, August 1st. Citigroup reiterated a "neutral" rating and set a $135.00 price objective (down from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. Finally, Jefferies Financial Group lowered their target price on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. One equities research analyst has rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Reduce" and a consensus price target of $134.08.

Insider Buying and Selling

In related news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the sale, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.57% of the stock is currently owned by insiders.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.